Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04348123 · ClinicalTrials.gov registry record · NA

Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography

A NA study of Breast Cancer, sponsored by Case Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
203
Enrollment target
1
Study location

NCT04348123: Active NA study of Breast Cancer, sponsored by Case Comprehensive Cancer Center.

NCT04348123 is a NA study of Breast Cancer that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 203 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04348123, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
203 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify interventions that are designed to better serve women who are homeless, with a specific focus on increasing screening rates and decreasing late stage breast cancer diagnosis among this high-risk understudied community of women. As a result, the study team hopes to influence the broader homeless healthcare initiative

Primary Outcome

Rate of women approached who agree to enter the outreach educational program

Conditions Studied

Interventions

  • OTHER Survey
  • BEHAVIORAL Education Session

Study Locations (1)

Ohio

  • Cleveland Clinic, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2022-03-15
Est. Completion 2025-11
Phase NA
Case Comprehensive Cancer Center

407 total trials

What the registry record for NCT04348123 still lists

NCT04348123 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Survey is the first listed.

NCT04348123 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04348123 about?

NCT04348123 is a clinical study titled "Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography". The purpose of this study is to identify interventions that are designed to better serve women who are homeless, with a specific focus on increasing screening rates and decreasing late stage breast cancer diagnosis among this high-risk understudied community of women. As a result, the study team hope...

What is the current status of trial NCT04348123?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 203 participants. The study started on 2022-03-15. Estimated completion is 2025-11.

What conditions does trial NCT04348123 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT04348123?

The interventions under investigation include: Survey (OTHER), Education Session (BEHAVIORAL).

Who is sponsoring clinical trial NCT04348123?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04348123 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04348123's enrollment target sits among peer trials

203 361st of 1224 higher than 864 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05652686 · 203 participants · Phase 1

    A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • NCT06063122 · 203 participants · NA

    Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

  • NCT07031245 · 203 participants · NA

    Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04348123, the US trial registry maintained by the National Library of Medicine. NCT04348123 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.